Overcoming Barriers to Care in Systemic Mastocytosis: Access, Equity, and What's Next

In the final episode, "Overcoming Barriers to Care in Systemic Mastocytosis: Access, Equity, and What's Next," the panelists explored the following critical questions:

Specialty pharmacy access is one of the most common real-world barriers for patients starting tyrosine kinase inhibitors. What are the most frequent challenges and how do pharmacists solve them?

What is the role of co-pay assistance programs?

How can pharmacists most effectively help patients gain insurance coverage for tyrosine kinase inhibitors?

What has your experience been like so far with insurance companies providing coverage for these therapies?

What are the remaining unmet needs in the care of patients with indolent systemic mastocytosis, and how do you see things evolving in the next 5 years?

How about with advanced systemic mastocytosis?

Led by the moderator, the panelists/expert pharmacists examined common specialty pharmacy and insurance barriers facing patients starting tyrosine kinase inhibitor therapy, sharing proactive strategies such as pre-identifying patient assistance and quick-start programs, securing copay assistance and grant funding, and writing data-driven appeal letters to support payer approvals. They emphasized the pharmacist's role as a care navigator who communicates directly with specialty pharmacies and payers to reduce delays and financial burden for patients. Looking ahead, the panelists identified key unmet needs, including longer-term tyrosine kinase inhibitor safety data, strategies to reduce treatment and polypharmacy burden, and continued efforts to close diagnostic delays and disparities, particularly in rural and community care settings.

Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

Thank you for watching this Practice Pearls series on systemic mastocytosis. Please subscribe to our newsletter for information on upcoming video series.